Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Larsen

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Acta Biochimica Polonica|November 20, 1998
DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53A K Larsen, C Gobert, C Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cellsK Bojanowski, S Lelievre, J Markovits, et al.
Leukemia|September 26, 1997
Natural resistance of acute myeloid leukemia cell lines to mitoxantrone is associated with lack of apoptosisJ D Bailly, A Skladanowski, A Bettaieb, et al.
British Journal of Pharmacology|March 3, 2004
Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effectsA K Larsen, L T Brennum, J Egebjerg, et al.
Anti-Cancer Drug Design|August 1, 1988
Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agentsC Auclair, M A Schwaller, B René, et al.
Cancer Research|December 1, 1989
Decreased accessibility of globotriaosylceramide associated with decreased tumorigenicity in Burkitt's lymphoma variants induced by immunoselectionS Junqua, A K Larsen, P Wils, et al.
Applied Biochemistry and Biotechnology|February 1, 1984
An immobilized microbial heparinase for blood deheparinizationR J Linhardt, C L Cooney, D Tapper, et al.
Science (New York, N.Y.)|July 16, 1982
An enzymatic system for removing heparin in extracorporeal therapyR Langer, R J Linhardt, S Hoffberg, et al.
Biochemical Pharmacology|October 19, 1993
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.
British Journal of Pharmacology|October 2, 2007
Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylationM-L Selenica, H S Jensen, A K Larsen, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Acta Biochimica Polonica|November 20, 1998
DNA topoisomerases as repair enzymes: mechanism(s) of action and regulation by p53A K Larsen, C Gobert, C Gilbert, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1992
Suramin is an inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cellsK Bojanowski, S Lelievre, J Markovits, et al.
Leukemia|September 26, 1997
Natural resistance of acute myeloid leukemia cell lines to mitoxantrone is associated with lack of apoptosisJ D Bailly, A Skladanowski, A Bettaieb, et al.
British Journal of Pharmacology|March 3, 2004
Selectivity of (3)H-MADAM binding to 5-hydroxytryptamine transporters in vitro and in vivo in mice; correlation with behavioural effectsA K Larsen, L T Brennum, J Egebjerg, et al.
Anti-Cancer Drug Design|August 1, 1988
Relationships between physicochemical and biological properties in a series of oxazolopyridocarbazole derivatives (OPCd); comparison with related anti-tumor agentsC Auclair, M A Schwaller, B René, et al.
Cancer Research|December 1, 1989
Decreased accessibility of globotriaosylceramide associated with decreased tumorigenicity in Burkitt's lymphoma variants induced by immunoselectionS Junqua, A K Larsen, P Wils, et al.
Applied Biochemistry and Biotechnology|February 1, 1984
An immobilized microbial heparinase for blood deheparinizationR J Linhardt, C L Cooney, D Tapper, et al.
Science (New York, N.Y.)|July 16, 1982
An enzymatic system for removing heparin in extracorporeal therapyR Langer, R J Linhardt, S Hoffberg, et al.
Biochemical Pharmacology|October 19, 1993
The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and IIA K Larsen, L Grondard, J Couprie, et al.
British Journal of Pharmacology|October 2, 2007
Efficacy of small-molecule glycogen synthase kinase-3 inhibitors in the postnatal rat model of tau hyperphosphorylationM-L Selenica, H S Jensen, A K Larsen, et al.
Pageof 7